Indication

Diarrhea predominant irritable bowel syndrome

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a chronic disorder of gut-brain interaction affecting the gastrointestinal system, primarily presenting in adolescents and adults with a higher prevalence in females. Read more about Diarrhea predominant irritable bowel syndrome

22 drugs 21 manufacturers

Advertisement

Drugs that treat it

Common Diarrhea predominant irritable bowel syndrome therapies.

Showing 1–9 of 22 drugs

XIFAXAN (rifaximin)

RIFAMYCINS·DIARRHEA PREDOMINANT IRRITABLE BOWEL SYNDROME·+2
SALIX/BAUSCH HE

XIFAXAN (rifaximin)

RIFAMYCINS·DIARRHEA PREDOMINANT IRRITABLE BOWEL SYNDROME·+2
SALIX PHARMACEU

ALOSETRON HCL

DIARRHEA PREDOMINANT IRRITABLE BOWEL SYNDROME
ROXANE LABS.

ALOSETRON HCL

DIARRHEA PREDOMINANT IRRITABLE BOWEL SYNDROME
ACTAVIS PHARMA,

ALOSETRON HCL

IRRITABLE BOWEL SYNDROME AGENTS·DIARRHEA PREDOMINANT IRRITABLE BOWEL SYNDROME
ROXANE/WEST-WAR
Filter & compare in the drug finder →Opens the drug finder with Diarrhea predominant irritable bowel syndrome preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Diarrhea predominant irritable bowel syndrome.

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a chronic disorder of gut-brain interaction affecting the gastrointestinal system, primarily presenting in adolescents and adults with a higher prevalence in females.

It is clinically characterized by recurrent abdominal pain related to defecation, accompanied by frequent, loose, or watery stools on more than 25% of bowel movement days without predominant constipation.

The underlying pathophysiology is multifactorial and involves dysregulated gut-brain signaling, accelerated intestinal transit, visceral hypersensitivity, altered gut microbiota, and increased intestinal mucosal permeability.

Personalize your experience

Follow Diarrhea predominant irritable bowel syndrome and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it